|
Hakkında:
|
A new Cycle 2 Research to Assess your Efficacy regarding gelatin inside Patients With EGFR Mutation-positive NSCLC That Developed Isolated CNS Progression (T790M-negative or Unknown) Through First- or perhaps Second-generation EGFR-TKI or even Systemic Ailment Advancement (T790M-negative) Right after Remedy Along with First- or perhaps Second-generation EGFR-TKI and Platinum-based Chemo (WJOG12819L)
|
